Ireland Medical only
IMPORTANT: Ireland's own program is one of the narrowest in Europe (only 3 qualifying conditions, ~74 approved patients total) — AND multiple sources confirm foreign medical cannabis products are NOT permitted into Ireland even with proper certificates.
Legal Framework
Cannabis possession is a criminal offense in Ireland under the Misuse of Drugs Act. A first offense for personal possession can bring a fine of up to €1,000 or up to 12 months in prison, though courts often use cautions or community service for first-time, small-quantity cases; repeat offenses carry harsher penalties, and cultivation or supply is treated far more severely.
Reform is under active discussion but not yet law. Ireland's Citizens' Assembly on Drugs Use recommended decriminalizing personal possession of all substances, distinguishing clearly between personal use and trafficking. An Oireachtas joint committee was tasked with a formal response by January 2025 and held hearings between September 2025 and April 2026; its report must still be reviewed by the Departments of Health, Justice and the Taoiseach before any Oireachtas debate, so as of mid-2026 the current criminal penalties remain fully in force.
Medical Cannabis Program
Ireland runs the Medical Cannabis Access Programme (MCAP), one of the narrowest medical cannabis schemes in Europe. It covers only three indications: spasticity associated with multiple sclerosis, nausea and vomiting from chemotherapy, and severe, treatment-resistant epilepsy - and only after standard treatments have failed. Access requires referral and prescription from a registered specialist consultant; a general practitioner cannot initiate treatment. A parallel ministerial license route allows case-by-case access for conditions outside MCAP, subject to approval from the Minister for Health.
The program's reach is extremely small: as of March 2026, only 74 patients nationwide had been approved under MCAP, referred by just 22 consultants. In response, the government appointed Professor Shane Allwright, a retired Trinity College Dublin epidemiologist, to chair a formal review of both MCAP and the ministerial license pathway, examining whether the narrow eligibility criteria should be widened. The review began in Q2 2025 and is due to report within twelve months.
Traveling with Medical Cannabis
This is the point where Ireland differs sharply from most of the rest of the EU: prescribed cannabis-based products are generally not permitted to be brought into Ireland, even with a valid prescription from another country. Irish customs actively screen incoming travelers, including with drug-detection dogs, and cannabis found without authorization can be confiscated, with consequences ranging from a caution to a fine or prosecution depending on the amount and circumstances. Ireland does not automatically recognize foreign medical cannabis prescriptions or patient cards.
In principle, Article 75 of the Schengen Implementing Convention allows travelers to carry physician-certified controlled medicines within Schengen countries for journeys of up to 30 days, and Ireland has previously examined adopting elements of this framework. In practice, however, official guidance treats cannabis as an exception requiring prior authorization that is rarely granted. Anyone needing to travel to Ireland with prescribed cannabis should contact the HSE, the Department of Health and Irish Customs well in advance - do not assume a foreign prescription, MCAP-equivalent approval, or Schengen certificate will be honored on arrival.
Recent Developments
- 2025-2026: formal review of MCAP and the ministerial license pathway underway, chaired by Professor Shane Allwright, expected to report roughly a year after starting in Q2 2025.
- 2025-2026: Oireachtas committee process on decriminalizing personal drug possession continues, with the resulting report still awaiting review by government departments as of mid-2026.
Frequently Asked Questions
Can I bring my prescribed medical cannabis into Ireland?
Generally, no. Ireland does not permit importing cannabis-based medicines, even with a valid foreign prescription, without prior authorization that is rarely granted. Confirm directly with the HSE, the Department of Health and Irish Customs before traveling.
Who qualifies for Ireland's own medical cannabis program?
Only patients with MS-related spasticity, chemotherapy-induced nausea, or severe treatment-resistant epilepsy, after standard treatments have failed, referred by a registered specialist consultant.
How many patients actually use the MCAP?
As of March 2026, just 74 patients nationwide, referred by only 22 consultants - among the smallest medical cannabis patient populations in Europe.
Could Ireland's cannabis laws change soon?
Two reform processes are underway - a review of the MCAP due to report around mid-2026, and an Oireachtas process on decriminalizing personal possession generally - but neither had resulted in a change of law as of mid-2026.